Lisdexamfetamine Dimesylate Capsules Solicitation

The Defense Logistics Agency (DLA) Troop Support is preparing to issue a solicitation for a national requirements contract to supply Lisdexamfetamine Dimesylate Capsules in multiple strengths, ranging from 10 mg to 70 mg, available in both 90-count and 100-count bottles. This acquisition will be fully competitive and unrestricted, employing a firm-fixed price, requirements type contract with a one-year base period and four subsequent one-year option periods. The contract aims to establish a national supply source to serve the Department of Defense, Indian Health Service, and Department of Veterans Affairs customers through DLA and VA prime vendor programs. The procurement of these commercial items will follow the guidelines of FAR part 12, with annual usage estimates outlined in the solicitation schedule. Solicitation details, including the Schedule of Supplies and annual usage estimates, will be posted on the DLA Bid Board System and SAM.gov, with a projected solicitation release date in March 2026, although the DLA reserves the right to adjust this timing. Interested vendors from all sources are encouraged to submit proposals, with automated notifications available for any pre-solicitation updates or changes. Points of contact for inquiries include Courtney Hunter and Jason Wray, who can be reached via email or phone as listed in the solicitation notice. The contract supports procurement efforts under NAICS code 325412, covering pharmaceutical manufacturing activities.